Related Experiment Video
Updated: Aug 23, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
1Oncology Department, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei 441000, P.R. China.
Abstract:
Aberrant DNA methylation leads to altered gene expression, resulting in cancerous features. Numerous tumor suppressor genes are silenced by DNA methylation during hepatocarcinogenesis. Promoter CpG island hypermethylation is an important mechanism for inactivating tumor suppressor genes in hepatocellular carcinoma (HCC). Hypermethylation of CpG islands in the p16 (INK4a) and p15 (INK4b) promoters may increase the risk of developing HCC, particularly hepatitis B virus-related HCC. Environmental factors can lead to geographic variations in the methylation status of CpG islands. Aberrant DNA methylation of CpG islands is catalyzed by DNA methyltransferases (DNMTs). Thus, abnormal variations of DNMTs can contribute to hepatocarcinogenesis. In hepatitis-related HCC, microRNAs participate in hepatocarcinogenesis by directly targeting DNMTs, during which hepatitis B virus X acts as a regulator. DNA methylation may also contribute to HCC tumorigenesis by regulating the cell cycle. Based on the importance of DNA methylation in tumor suppression of HCC, certain DNA methylations may predict the risk of tumor development, tumor staging, patient survival and HCC recurrence.
Insights
Aberrant DNA methylation silences tumor suppressor genes, increasing hepatocellular carcinoma (HCC) risk. DNA methylation patterns may predict HCC development, staging, and patient outcomes.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Aberrant DNA methylation is a key mechanism in cancer development, particularly in hepatocellular carcinoma (HCC).
- Silencing of tumor suppressor genes via promoter CpG island hypermethylation is prevalent in HCC.
- Environmental factors influence DNA methylation patterns, contributing to geographic variations in HCC incidence.
Purpose of the Study:
- To investigate the role of DNA methylation in hepatocellular carcinoma (HCC) pathogenesis.
- To explore the association between CpG island hypermethylation and HCC risk, especially in hepatitis B virus-related cases.
- To determine the potential of DNA methylation as a biomarker for HCC prognosis.
Main Methods:
- Analysis of DNA methylation status in HCC tissues and relevant gene promoters (e.g., p16 INK4a, p15 INK4b).
- Investigation of the role of DNA methyltransferases (DNMTs) and microRNAs in hepatitis-related HCC.
- Correlation of methylation profiles with clinical parameters including tumor stage and patient survival.
Main Results:
- Promoter hypermethylation of tumor suppressor genes like p16 (INK4a) and p15 (INK4b) is linked to increased HCC risk.
- Aberrant DNA methyltransferases (DNMTs) and microRNA dysregulation, influenced by hepatitis B virus X, contribute to hepatocarcinogenesis.
- DNA methylation alterations correlate with HCC development, staging, survival, and recurrence.
Conclusions:
- DNA methylation is a critical factor in HCC development and progression.
- Specific DNA methylation markers hold potential for predicting HCC risk and patient outcomes.
- Targeting DNA methylation pathways may offer therapeutic strategies for HCC.
Related Concept Videos
Epigenetic Regulation
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...

